In a study of 162 infants treated with long acting ACTH at this hospital side effects, in some cases grave, were more common than in previous reports.2 In two of the infants serum calcium and inorganic phosphate concentrations and serum alkaline phosphatase activity were followed during the treatment; the concentrations and activity were low and the infants developed osteoporosis. These findings and an earlier report on ACTH induced osteoporosis in children3 prompted a (retrospective) study of the kidneys of five infants with fatal outcome of this treatment and a (prospective) study of its effects on mineral metabolism. Our findings suggest that nephrocalcinosis is common and mineral homeostasis is often disturbed, even during the relatively short six week (but high dose) treatment used at this hospital.
For 25 years adrenocorticotrophic hormone (ACTH) has been the drug of choice for infantile spasms. It usually abolishes the seizures, and relapses are less common than with conventional anticonvulsive treatment.' The dosage used varies from 10 to 180 units daily and the duration of treatment from three weeks to 10 months.
In a study of 162 infants treated with long acting ACTH at this hospital side effects, in some cases grave, were more common than in previous reports.2 In two of the infants serum calcium and inorganic phosphate concentrations and serum alkaline phosphatase activity were followed during the treatment; the concentrations and activity were low and the infants developed osteoporosis. These findings and an earlier report on ACTH induced osteoporosis in children3 prompted a (retrospective) study of the kidneys of five infants with fatal outcome of this treatment and a (prospective) study of its effects on mineral metabolism. Our findings suggest that nephrocalcinosis is common and mineral homeostasis is often disturbed, even during the relatively short six week (but high dose) treatment used at this hospital.
Material and methods
The kidneys of five infants with fatal outcome of treatment with ACTH were examined (retrospective series). We then studied (prospective series) 16 of the 22 infants treated at this hospital for infantile spasms during a two year period (Table) . All infants were given carboxymethylcellulose corticotrophin (Acortan prolongatum, Ferring, Malmo, Sweden) intramuscularly every morning for six weeks. Three of the infants in the retrospective series and all the infants in the prospective series received 120 units during weeks 1 to 3 and 60 units during weeks 4 and 5. Treatment was tapered during and stopped at the end of week 6. The two other infants in the retrospective series received one half of that dosage.
Before treatment each infant was assessed for aetiology (Table) . Four infants had had no previous treatment and 12 received anticonvulsants before and during treatment with ACTH. From age 2-3 weeks every infant had been supplemented with 1000 IU vitamin D daily. The diet consisted of an adapted milk formula (the whey:casein ratio being 60:40), with supplemental food from age 3 months. The ethics committee of the hospital approved the study. Informed consent was obtained from all parents. 
Results
Nephrocalcinosis. None of the five infants with fatal outcome (retrospective series) had signs of renal failure; they died of fulminant infections. Their kidneys were macroscopically normal. Microscopy showed severe tubular and interstitial nephrocalcinosis (Fig. 1) . Three of them had had metabolic alkalosis (base excess ranging from 8 to 12). One of them had severe and two others moderate hypokalaemia (2-2, 3-2, and 3-2 mmol/l, respectively); all others were normokalaemic. Urine pH was not measured.
All eight infants studied for urine pH in the prospective group had values > 7 5 during the treatment. Three of them had metabolic alkalosis with base excess ranging from 11-5 to 11-7 mmol/l. 710 (637-791) IU/l to 265 (226-312) IU/l (geometric mean (SEM); normal <1000 IU/l) (p<0001) (Fig. 3) . It increased markedly in one infant (case 9) with severe secondary hyperparathyroidism (see below). Isoenzymes were studied in eight patients (including case 9). The changes were in the thermolabile (bone) isoenzyme, which accounted for 70 to 100% of the total activity. Serum PTH concentration. PTH concentrations increased in eight of the nine infants followed (Fig.  4) . The (Fig. 2) . In three infants the concentration became subnormal and in three others supranormal.
The mean serum phosphate concentration fell from 1-79 (0.06) mmol/l to 1-47 (0.08) (p<0.005) during the treatment (Fig. 1) . Seven infants became hypophosphataemic. In one infant the concentration clearly increased, with a corresponding decrease in serum PTH concentration (case 8, see below).
Daily urine calcium, phosphate, cAMP, and creatinine concentrations and amino acids. During the treatment the mean (SEM) daily urine calcium concentration increased from 0-046 (0.008) mmol/ kg to 0-108 (0-014) mmol/kg (p<0O001) (Fig. 2) . Hypercalciuria Ten of the 16 infants developed generalised aminoaciduria; in three of them this was severe. One of the three infants (case 9) had hyperparathyroidism; serum PTH concentration was not determined in the others. min, magnesium, creatinine, and urea concentrations were within normal limits.
Reversibility of the biochemical changes. The mean serum calcium concentration increased to 2-62 (0.04) mmol/l after the treatment (for the difference between the values during and after treatment with ACTH p<0 01; Fig. 2 ). Serum phosphate concentration increased to 1-76 (0.06) mmol/l (p<0.02). Daily urinary calcium and phosphate excretion decreased to pretreatment amounts, 037 (0-01) mmollkg (p<0-02) and 0-68 (0-10) mmol/kg (p<0-1), respectively. TRCa rose to 0 94 (0.02) (p<0-1) and TRP to 0-91 (0-00) (p<01). The supranormal serum alkaline phosphatase activity of case 9 normalised (Fig. 3) . In another seven infants followed after treatment the concentration rose to 514 (450-587) IU/l (geometric mean (SEM)) (p<0-2).
Serum PTH concentration was measured in four infants after treatment. The concentrations decreased slightly. The hyperaminoaciduria disappeared after treatment. Daily urinary cAMP also returned to lower amounts (p<0-1).
Radiographic findings. Bone mass decreased in all 14 patients who had serial radiographs. The whole cancellous bone was affected. In the metaphyseal region the demineralisation occurred after only two weeks of treatment. The provisional zone of ossification contrasted sharply against the physis, giving a band like appearance. Slight metaphyseal cupping suggested rickets in four infants (cases 2, 4, 9, and 13). Three of them had subperiosteal resorption and rarefaction of cancellous bone. Two of them were on treatment with anticonvulsants.
The radiographic changes were reversible. All eight infants restudied after treatment showed clear remineralisation of the cancellous bone. 
